Dogwood Therapeutics to attend 2026 Maxim Growth Summit

DWTX•2026-10-06

Dogwood Therapeutics will participate in the 2026 Maxim Growth Summit in New York on Oct. 12-14, with CEO Greg Duncan scheduled for one-on-one meetings with institutional investors.

1. Summit participation

Dogwood Therapeutics will participate in the 2026 Maxim Growth Summit in New York on Oct. 12-14. CEO Greg Duncan is scheduled for one-on-one meetings with institutional investors during the event.

Dogwood Therapeutics to attend 2026 Maxim Growth Summit

1. Summit participation

Related News

bioAffinity says CyPath Lung test sales more than double through Q3 2026

ArriVent's oral lung cancer therapy fails late-stage trial, shares plunge

Voyager Technologies awarded cancer research mission management contract

OpenTable extends Visa dining partnership across US, Canada and Mexico

Volaris September load factor rises 1.0 pp to 84.4%